参考文献/References:
[1] CECH T R.Evolution of biological catalysis: Ribozyme to RNP enzyme[J].Cold Spring HarbSymp Quant Biol,2009,74:11-16.DOI:10.1101/sqb.2009.74.024.
[2] MOORE P B,STEITZ T A.The roles of RNA in the synthesis of protein[J].Cold Spring Harbor Perspectives in Biology,2011,3(11):a003780.DOI:10.1101/cshperspect.a003780.
[3] ALTMAN S.Ribonuclease P: An enzyme with a catalytic RNA subunit[J].Adv Enzymol Relat Areas Mol Biol,1989,62:1-36.
[4] KRUGER K,GRABOWSKI P J,ZAUG A J,et al.Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena[J].Cell,1982,31(1):147-157.
[5] PEEBLES C L,PERLMAN P S,MECKLENBURG K L,et al.A self-splicing RNA excises an intron lariat[J].Cell,1986,44(2):213-223.
[6] PRODY G A,BAKOS J T,BUZAYAN J M,et al.Autolytic processing of dimeric plant virus satellite RNA[J].Science,1986,231(4745):1577-1580.
[7] HAMPEL A,TRITZ R.RNA catalytic properties of the minimum(-)sTRSV sequence[J].Biochemistry,1989,28(12):4929-4933.
[8] FELDSTEIN P A,BUZAYAN J M,BRUENING G.Two sequences participating in the autolytic processing of satellite tobacco ringspot virus complementary RNA[J].Gene,1989,82(1):53-61.
[9] SHARMEEN L,KUO M Y,DINTER-GOTTLIED G,et al.Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage[J].J Virol,1988,62(8):2674-2679.
[10] SAVILLE B J,COLLINS R A.A site-specific self-cleavage reaction performed by a novel RNA in neurospora mitochondria[J].Cell,1990,61(4):685-696.
[11] NIELSEN H,WESTHOF E,JOHANSEN S.An mRNA is capped by a 2’, 5’ lariat catalyzed by a group I-like ribozyme[J].Science,2005,309(5740):1584-1587.
[12] BAN N,NISSEN P,HANSEN J,et al.The complete atomic structure of the large ribosomal subunit at 2.4 A resolution[J].Science,2000,289(5481):905-920.
[13] WINKLER W C,NAHVI A,ROTH A,et al.Control of gene expression by a natural metabolite-responsive ribozyme[J].Nature,2004,428(6980):281-286.
[14] ROTH A,WEINBERG Z,CHEN A G Y,et al.A widespread self-cleaving ribozyme class is revealed by bioinformatics[J].Nature Chemical Biology,2014,10(1):56-60.
[15] WEINBERG Z,KIM P B,CHEN T H,et al.New classes of self-cleaving ribozymes revealed by comparative genomics analysis[J].Nature Chemical Biology,2015,11(8):606-610.
[16] LI S,LÜNSE C E,HARRIS K A,et al.Biochemical analysis of hatchet self-cleaving ribozymes[J].RNA,2015,21(11):1845-1851.DOI:10.1261/rna.052522.115.
[17] HARRIS K A,LÜNSE C E,LI S,et al.Biochemical analysis of pistol self-cleaving ribozymes[J].RNA,2015,21(11):1852-1858.DOI:10.1261/rna.052514.115.
[18] NGUYEN L A,WANG J,STEITZ T A.Crystal structure of Pistol, a class of self-cleaving ribozyme[J].Proceedings of the National Academy of Sciences,2017,114(5):1021-1026.DOI:10.1073/pnas.1611191114.
[19] REN A,VU?UROVI? N,GEBETSBERGER J,et al.Pistol ribozyme adopts a pseudoknot fold facilitating site-specific in-line cleavage[J].Nature Chemical Biology,2016,12(9):702-708.
[20] de la PE(~overN)A M,GARCÍA-ROBLES I,CERVERA A.The hammerhead ribozyme: A long history for a short RNA[J].Molecules,2017,22(1):78.
[21] SARVER N,CANTIN E M,CHANG P S,et al.Ribozymes as potential anti-HIV-1 therapeutic agents[J].Science,1990,247(4947):1222-1226.
[22] HABU Y,MIYANO-KUROSAKI N,TAKEUCHI H,et al.Inhibition of HIV-1 replication by the Cre-loxP hammerhead ribozyme[J].Nucleosides, Nucleotides and Nucleic Acids,2001,20(4/5/6/7):723-726.
[23] GIORDANO V,JIN D Y,REKOSH D,et al.Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol[J].Virology,2000,267(2):174-184.
[24] WANG L I,WITHERINGTON C,KING A,et al.Preclinical characterization of an anti-tat ribozyme for therapeutic application[J].Human Gene Therapy,1998,9(9):1283-1291.DOI:10.1089/hum.1998.9.9-1283.
[25] WYSZKO E,BARCISZEWSKA M Z,BALD R,et al.The specific hydrolysis of HIV-1 TAR RNA element with the anti-TAR hammerhead ribozyme: Structural and functional implications[J].International Journal of Biological Macromolecules,2001,28(5):373-380.
[26] LARSSON S,HOTCHKISS G,SU Jin,et al.A novel ribozyme target site located in the HIV-1 nef open reading frame[J].Virology,1996,219(1):161-169.
[27] RAMEZANI A,DING S F,JOSHI S.Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes[J].Gene Therapy,1997,4(8):861-867.
[28] SCARBOROUGH RJ,GATIGNOL A.HIV and ribozymes[J].Adv Exp Med Biol,2015,848:97-116.
[29] OPALINSKA J B,GEWIRTZ A M.Nucleic-acid therapeutics: Basic principles and recent applications[J].Nature Reviews Drug Discovery,2002,1(7):503-514.DOI:10.1038/nrd837.
[30] FEDORUK-WYSZOMIRSKA A,SZYMASKI M,GÍODOWICZ P,et al.Inhibition of HIV-1 gp41 expression with hammerhead ribozymes[J].Biochemical Journal,2015,471(1):53-66.DOI:10.1042/BJ20150398.
[31] PELLETIER R,CARON S O P,PUYMIRAT J.RNA based gene therapy for dominantly inherited diseases[J].Current Gene Therapy,2006,6(1):131-146.
[32] ZENG W,CHEN Y C,BAI Y,et al.Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme[J].PLoS One,2012,7(12):e51855.
[33] FEDORUK-WYSZOMIRSKA A,SZYMA(~overN)SKI M,GÍODOWICZ P,et al.Inhibition of HIV-1 gp41 expression with hammerhead ribozymes[J].Biochemical Journal,2015,471(1):53-66.
[34] BAI J,ROSSI J,AKKINA R.Multivalent anti-CCR5 ribozymes for stem cell-based HIV type 1 gene therapy[J].AIDS Research and Human Retroviruses,2001,17(5):385-399.
[35] MITSUYASU R T,MERIGAN T C,CARR A,et al.Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells[J].Nature Medicine,2009,15(3):285-292.
[36] WELCH P J,TRITZ R,YEI S,et al.Intracellular application of hairpin ribozyme genes against hepatitis B virus[J].Gene Ther,1997,4(7):736-743.
[37] TAN T M C,ZHOU L,HOUSSAIS S,et al.Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozyme[J].Antisense and Nucleic Acid Drug Development,2002,12(4):257-264.
[38] DAI Wei,ZHOU Rong,YU Hong,et al.Inhibition of hepatitis B virus replication and expression in vitro and in vivo by the hammerhead ribozymes targeted different sites[J].Infection International,2012(4):206-210.
[39] 贾战生,周永兴.锤头结构核酶在人肝癌细胞内对丙型肝炎病毒基因表达的抑制作用[J].中华医学杂志,1999,79(8):631-632.
[40] RYU K J,KIM J H,LEE S W.Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing[J].Molecular Therapy,2003,7(3):386-395.
[41] 张文军,刘碧瑜,周玉珍,等.一种 HCV 靶向性 M1GS 核酶的构建及其体外活性[J].基础医学与临床,2011,31(1):84-88.
[42] 张文军,李喜芳,罗桂飞,等.丙肝病毒核心基因靶向性 M1GS 核酶的体外抗病毒活性[J].微生物学报,2013,53(8):875-881.
[43] 李小英,伍婧茹,刘琳,等.AIVPB2基因靶向性M1GS核酶的构建及其体外切割活性测定[J].广东药学院学报,2017,33(1):1-5.
[44] ALVAREZ-SALAS L M,BENÍTEZ-HESS M L,DIPAOLO J A.Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses[J].Antiviral Therapy,2003,8(4):265-278.
[45] LU D,CHATTERJEE S,BRAR D,et al.Ribozyme-mediated in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16[J].Cancer Gene Therapy,1994,1(4):267-277.
[46] LIU D Z,JIN Y X,HOU H,et al.Preparation and identification of activity of anti-HPV-6b/11E1 universal ribozyme: Rz1198 in vitro[J].Asian Journal of Andrology,1999,1(4):195-201.
[47] ZHENG Y,ZHANG J,RAO Z.Ribozyme targeting HPV16 E6E7 transcripts in cervical cancer cells suppresses cell growth and sensitizes cells to chemotherapy and radiotherapy[J].Cancer Biology and Therapy,2004,3(11):1129-1134.
[48] 饶智国,高建飞,章必成,等.特异性核酶增强宫颈癌细胞对多种化疗药物的敏感度研究[J].肿瘤防治研究,2011,38(5):512-514.
[49] 饶智国,高建飞,章必成,等.抗HPV16E6核酶对宫颈癌CaSki细胞顺铂敏感性影响和机制的探讨[J].中华肿瘤防治杂志,2011,18(11):851-855.
[50] SADPVMOL I, HERRMANN H, EISENWORT G, et al. Expression of CD25 on leukemic stem cells in BCR-ABL1(+)CML: Potential diagnostic value and functional implications[J].Exp Hematol,2017,51:17-24.
[51] LEOPOLD L H,SHORE S K,NEWKIRK T A,et al.Multi-unit ribozyme-mediated cleavage of BCR-ABL mRNA in myeloid leukemias[J].Blood,1995,85(8):2162-2170.
[52] 付辉,李菲菲,马琼,等.逆转录法筛选 mRNA 靶点设计核酶对 GPA 的表达干预实验研究[J].中国生物工程杂志,2014,34(3):84-90.
[53] KUWABARA T,WARASHINA M,TANABE T,et al.A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo[J].Mol Cell,1998,2(5):617-627.
[54] TANABE T,KUWABARA T,WARASHINA M,et al.Oncogene inactivation in a mouse model[J].Nature,2000,406(6795):473-474.
[55] SODA Y,TANI K,BAI Y,et al.A novel maxizyme vector targeting a BCR-ABL fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia[J].Blood,2004,104(2):356-363.
[56] 吴勇,陈元仲,黄慧芳,等.针对BCR/ABL的锤头状核酶的骨髓净化作用[J].生物化学与生物物理学报(英文版),2003,35(9):859-863.
[57] 周颖,毛建平.Ribozyme和DNAzyme的基因治疗实验应用进展[J].中国生物工程杂志,2010,30(6):122-129.
[58] 王巍杰,杨永强,徐长波.基因治疗导入载体的研究进展[J].生物技术通报,2010(2):38-41.
[59] ROUGE J L,SITA T L,HAO L,et al.Ribozyme-spherical nucleic acids[J].Journal of the American Chemical Society,2015,137(33):10528-10531.DOI:10.1021/jacs.5b07104.